JPMorgan Chase & Co. Issues Positive Forecast for Privia Health Group (NASDAQ:PRVA) Stock Price

Privia Health Group (NASDAQ:PRVA - Free Report) had its price target lifted by JPMorgan Chase & Co. from $29.00 to $32.00 in a research report report published on Wednesday,Benzinga reports. The firm currently has an overweight rating on the stock.

PRVA has been the topic of a number of other reports. Robert W. Baird upped their target price on shares of Privia Health Group from $24.00 to $26.00 and gave the company an "outperform" rating in a research report on Tuesday, April 15th. Needham & Company LLC reiterated a "buy" rating and set a $30.00 target price on shares of Privia Health Group in a report on Thursday, April 10th. Piper Sandler upped their price target on shares of Privia Health Group from $25.00 to $40.00 and gave the company an "overweight" rating in a report on Friday, February 28th. JMP Securities restated a "market outperform" rating and set a $29.00 price objective on shares of Privia Health Group in a report on Monday, April 28th. Finally, Canaccord Genuity Group boosted their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a research report on Friday, February 28th. One analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Buy" and a consensus target price of $27.77.

Privia Health Group Trading Up 1.4%

Shares of Privia Health Group stock traded up $0.31 during midday trading on Wednesday, reaching $22.86. The company had a trading volume of 1,260,625 shares, compared to its average volume of 739,072. The stock has a fifty day simple moving average of $23.34 and a 200 day simple moving average of $22.72. Privia Health Group has a 1-year low of $16.37 and a 1-year high of $26.09. The company has a market capitalization of $2.79 billion, a price-to-earnings ratio of 228.62, a price-to-earnings-growth ratio of 3.47 and a beta of 0.87.

Insider Activity at Privia Health Group

In other Privia Health Group news, CEO Parth Mehrotra sold 15,100 shares of Privia Health Group stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total transaction of $352,283.00. Following the completion of the transaction, the chief executive officer now directly owns 454,281 shares of the company's stock, valued at $10,598,375.73. The trade was a 3.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO David Mountcastle sold 5,630 shares of the company's stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total transaction of $125,999.40. Following the completion of the transaction, the chief financial officer now owns 179,676 shares in the company, valued at approximately $4,021,148.88. This represents a 3.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 51,579 shares of company stock valued at $1,226,367. Insiders own 10.70% of the company's stock.

Institutional Trading of Privia Health Group

A number of hedge funds have recently modified their holdings of the stock. First Horizon Advisors Inc. increased its position in Privia Health Group by 53.8% during the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock worth $35,000 after acquiring an additional 632 shares during the period. CWM LLC grew its holdings in shares of Privia Health Group by 50.3% during the 1st quarter. CWM LLC now owns 1,804 shares of the company's stock valued at $40,000 after purchasing an additional 604 shares during the last quarter. EverSource Wealth Advisors LLC lifted its stake in shares of Privia Health Group by 7,833.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company's stock valued at $47,000 after acquiring an additional 2,350 shares during the last quarter. Bessemer Group Inc. grew its holdings in shares of Privia Health Group by 2,393.4% during the first quarter. Bessemer Group Inc. now owns 2,269 shares of the company's stock worth $51,000 after purchasing an additional 2,178 shares during the last quarter. Finally, Russell Investments Group Ltd. lifted its holdings in shares of Privia Health Group by 2,852.2% during the first quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company's stock worth $60,000 after purchasing an additional 2,567 shares during the period. Institutional investors and hedge funds own 94.48% of the company's stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.